When designing screening programmes or advice for clinicians on opportunistic screening, it may be necessary to consider the possibility that the identified differences in PSA distribution and prostate cancer incidence in the different ethnic groups may lead to differential under- or over-diagnosis in certain groups. The gene discussed is KLK3; the disease is Familial prostate cancer.